« Back
Home /
GLP-1 receptor agonist 1

GLP-1 receptor agonist 1

€11,526.00

Excl. VAT

Item no.	TMO-T11408-100mg
Manufacturer	TargetMol
CASRN	2212020-52-3
Amount	100mg
Category	Metabolism Diabetes Glucose Homeostasis Reagents & Chemicals Molecules
Type	Molecules
Format	Powder
Specific against	other
Purity	0,98
Smiles	C[C@@H]1[C@](C1)(N2C=3C(C=C2C(=O)N4[C@@H](C)C5=C(N(N=C5CC4)C6=CC(C)=C(F)C(C)=C6)N7C(=O)N(C=C7)C=8C(F)=C9C(=CC8)N(C)N=C9)=CC(=CC3)[C@@H]%10CC(C)(C)OCC%10)C=%11NC(=O)ON%11
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	2212020-52-3, LY3502970 , GLP-1 receptor agonist 1
Available
Short Description	Orforglipron is an orally available glucagon-like peptide (GLP-1) receptor agonist for the study of obesity and type 1 diabetes in adults.
Shipping	cool pack
Storage	-20°
Target names or alias	LY3502970 , GLP-1 receptor agonist 1
Molecular Weight	882, 96
Pathway	GPCR/G Protein
Target	Glucagon Receptor

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T11408-100mg-datasheet.pdf

TMO-T11408-100mg-safety-datasheet.pdf